Bipolar Disorder & Schizophrenia: Dispelling Myths About Violence
Individuals with bipolar disorder or schizophrenia are not inherently dangerous. Stigma linking these conditions to violence is scientifically unfounded and socially harmful.
What the Evidence Shows
- People with serious mental illness (SMI) are 10–12 times more likely to be victims of violent crime than perpetrators.
- Violence risk in SMI is primarily driven by comorbid substance use, past violence, and socioeconomic factors—not the diagnosis itself.
- When treated, violence rates in schizophrenia/bipolar approach population norms.
Understanding the Conditions
- Bipolar disorder: Episodes of mania/hypomania and depression. Psychotic features may occur in severe mood episodes.
- Schizophrenia: Chronic psychosis (hallucinations, delusions, disorganization) with negative symptoms (avolition, blunted affect).
- Schizoaffective disorder: Mood episodes + psychotic symptoms independent of mood.
Reducing Stigma
- Use person-first language: "person with schizophrenia," not "schizophrenic."
- Challenge media portrayals linking mental illness to violence.
- Support access to early intervention, housing, and employment.
When Risk Is Elevated
Clinical risk assessment (e.g., HCR-20) considers:
- Active command hallucinations to harm
- Persecutory delusions with threat perception
- Substance intoxication
- History of violence
These require targeted intervention, not blanket discrimination.
Bottom line: Compassion and evidence-based care—not fear—improve outcomes for individuals and communities.
Bipolar Disorder - Related Articles
- Understanding Medications for Bipolar Disorder: Types & Options
- Understanding Bipolar Disorder in Adults: Symptoms, Causes & Treatment
- Understanding Bipolar Disorder: Symptoms, Causes & Treatment
- Manic Episodes During Bipolar Treatment: What to Expect
- Marijuana & Depakote: Understanding Interactions with Bipolar Disorder
- Juvenile Bipolar Disorder: Symptoms, Signs & Early Detection
- Depakote for Bipolar Disorder: Understanding Therapeutic Levels & Dosage
